Director · Roivant Sciences Ltd. · Roivant Sciences Ltd. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
10.5K
Price
—
Executed
Sep 16, 2026
Disclosed
Sep 18, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 16 executedSep 18, 2026 disclosed
ROIV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Roivant Sciences Ltd. — Stock Option (Right to Buy)
Ticker
ROIV
Shares
10.5K
Price per share
$0
Execution date (reported)
Sep 16, 2026
Owned after transaction
10.5K shares
Days from execution to publication
2
What this establishes
Gold Daniel Allen filed this Form 4 reporting a grant or award of ROIV on Sep 16, 2026. It became public on Sep 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Gold Daniel Allencik:0001832142
Issuer
Roivant Sciences Ltd.cik:0001635088
Revision history · 0
No field has changed since this record was first ingested.
